Health Tech
Insights

Market Players

Alibaba Health

Atone

CureMD

Docdoc

Docvita

eucalyptus

Good doctor

Gynoveda

halodoc

Healthengine

healthifyMe

Hulmusk

intellect

Mednefits

Mindfi

Mobio

Mydoc

naluri

Okadoc

Pharmeasy

Prenetics

Roche

SafeSpace

speedoc

teladoc

Thoughtfull

United Health

Vezeeta

Vively

Zenyum

Why 2025 Marks Healthcare’s Biggest Leap Into Personalised Digital Medicine

Health technology in 2025 is marked by a clear shift toward personalised, preventative and connected care. AI has moved from experimentation to core infrastructure, with GenAI and agentic systems embedded across diagnostics, operations and coaching. Consumers are driving rapid adoption: advanced wearables now provide medical-grade insights—from sleep and HRV to non-invasive glucose tracking—seamlessly feeding health apps and delivering real-time prompts on nutrition, recovery and behaviour. Remote Patient Monitoring, telehealth and hybrid care have become standard, blending at-home convenience with in-clinic diagnostics for continuous, outcome-driven health management. Precision health is accelerating through integrated data, digital twins and personalisation engines, while longevity, performance and holistic wellbeing become key differentiators. FemTech is finally attracting broader investment, expanding beyond fertility to advance women’s health data and literacy. New regulations, cybersecurity demands and logistics technologies are also reshaping how health organisations scale. The global digital health market is forecast to hit $639.4B by 2026 (28.5% CAGR), with Asia-Pacific leading growth on the back of stronger connectivity and active venture funding. Recent major deals—including CentralReach’s $1.7B acquisition, Bain Capital’s move on HealthEdge and Isomorphic Labs’ $600M raise—signal a consolidating market, alongside IPOs from Hinge Health and Omada Health. Together, these forces point to a future of proactive, AI-enabled, hyper-personalised health.

Edward Zouroudis

Co-Founder & CEO,
Evolt

In 2025, we’ve seen a global shift toward data-driven personalisation in health and fitness. The industry is moving beyond traditional tracking and aesthetics to focus on metabolic health, longevity, and preventative care. This evolution is being accelerated by the integration of intelligent technology, from body health analysers to AI-driven platforms, giving people and businesses the ability to make informed, actionable decisions based on real data. At Evolt, we’ve witnessed how empowering individuals with their own health biometrics can redefine engagement, retention, and overall wellness outcomes. As we move into 2026, the future belongs to those who can translate data into daily behaviour change and deliver measurable health improvements at scale.”

As we reflect on 2025, ŌURA has cemented its position as a leader in personalized health technology, empowering people to take control of their health and wellbeing. We’ve seen this firsthand through our community’s embrace of continuous health monitoring and the shift from reactive to preventive care—surpassing 5.5 million rings sold, with more than half in the past year alone. The launch of Oura Ring 4 Ceramic marked more than a product milestone—it expanded our reach to a new generation, seamlessly blending wellness with personal expression. By combining advanced insights with timeless design, we’re making health tracking both stylish and engaging. Looking ahead to 2026, longevity will take center stage as people gain deeper insight—through wearables like Oura Ring—into how today’s choices shape long-term health. In parallel, AI is coming of age in preventive care, advancing the science of prediction and personalization in ways that make health insights more timely and actionable. As these capabilities mature, human oversight remains essential. The future of AI in healthcare depends on clear boundaries and guardrails so that it evolves as a responsible and trusted partner to human care teams

Tom Hale

CEO,
ŌURA

Will Ahmed

Founder & CEO,
WHOOP®

We’ve really seen an explosion of [WHOOP] interest in the last five years from everyday folks who are aspirational – who want to take back control of their health. We recently announced Advanced Labs, which is launching later this year, and that’s going to allow people to do blood tests through Whoop for the first time, [and] understand how sleep and exercise habits potentially affect overall blood panels and biomarkers. A challenge that so many people have is that the data related to their health lives in different places. You’ve got data with your doctor’s office; you’ve got data in a health app. You’ve got a blood test you did; maybe an MRI. They don’t talk to each other. It’s really important that Whoop helps our members make sense of all this information.

2025 has been a year to steady the ship and ensure we have our existing business performing at optimal levels. Deals have seemed harder to come by, and slower to close, however we are seeing better performance in terms of revenue and retention across our entire network and we have set some things up for a big 2026. We have been working hard on a few new markets that look like they will open up for us in the new year, and this is part of my optimism and excitement for 2026. I’m also incredibly excited with the launch of EliteFit Advisory Group and the reception that the industry has given us has been nothing short of amazing, and I am looking forward to working with many new clients.

Russell Harrison

CRO,
Spartans Boxing Club
and Founder & CEO,
EliteFit Advisory Group

Health Tech Insights